GRI Bio, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

31.42 k

Shareholding (Mar 2025)

FII

0.03%

Held by 2 FIIs

DII

99.04%

Held by 1 DIIs

Promoter

0.00%

How big is GRI Bio, Inc.?

22-Jun-2025

As of Jun 18, GRI Bio, Inc. has a market capitalization of 3.19 million, classifying it as a Micro Cap company, with net sales of 0.00 million and a net profit of -9.37 million over the latest four quarters. As of Dec'24, the company reported shareholder's funds of 4.03 million and total assets of 5.74 million.

What does GRI Bio, Inc. do?

22-Jun-2025

GRI Bio, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $3.19 million. Key financial metrics indicate it is not profitable, with a negative return on equity and no dividend yield.

Is GRI Bio, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, GRI Bio, Inc. shows a mildly bullish technical trend, supported by MACD and KST indicators, despite significant underperformance compared to the S&P 500.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 4 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.53

Return on Equity

-301.29%

Price to Book

1.18

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

46.58%

6 Months

58.52%

1 Year

-81.16%

2 Years

-99.82%

3 Years

790.92%

4 Years

-100.0%

5 Years

0.0%

GRI Bio, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is GRI Bio, Inc. technically bullish or bearish?

As of 12 September 2025, the technical trend for GRI Bio, Inc. has changed from sideways to mildly bullish. The MACD is indicating a mildly bullish stance on both weekly and monthly time frames, while the KST also supports this with a mildly bullish signal. The Bollinger Bands show a bullish outlook on the weekly chart but are mildly bearish on the monthly. Moving averages are currently mildly bearish on the daily chart, which contrasts with the overall mildly bullish trend. The Dow Theory indicates a mildly bullish stance on the monthly timeframe, but no trend is present on the weekly. In terms of performance, GRI Bio, Inc. has underperformed significantly compared to the S&P 500, with a year-to-date return of -86.3% versus the S&P's 12.22%, and a one-year return of -76.01% compared to the S&P's 17.14%. Overall, the current technical stance is mildly bullish, driven primarily by the MACD and KST indicato...

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

0.00%

EBIT Growth (5y)

27.66%

EBIT to Interest (avg)

-5.06

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-2.68

Sales to Capital Employed (avg)

0.01

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

3.56%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.69

EV to EBIT

-0.00

EV to EBITDA

EV to Capital Employed

-0.00

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-777.43%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (0.93%)

Foreign Institutions

Held by 2 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -26.09% vs 65.67% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.90",
          "val2": "-2.30",
          "chgp": "-26.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.90",
          "val2": "-2.30",
          "chgp": "-26.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 36.92% vs -306.25% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.20",
          "val2": "-11.30",
          "chgp": "27.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "2.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.20",
          "val2": "-13.00",
          "chgp": "36.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-2.90

-2.30

-26.09%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-2.90

-2.30

-26.09%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -26.09% vs 65.67% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-8.20

-11.30

27.43%

Interest

0.00

2.10

-100.00%

Exceptional Items

0.00

0.20

-100.00%

Consolidate Net Profit

-8.20

-13.00

36.92%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 36.92% vs -306.25% in Dec 2023

All Annual Results

Company CV

About GRI Bio, Inc.

GRI Bio, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

GRI Bio, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is GRI Bio, Inc.?

Watch in Real-Time

What does GRI Bio, Inc. do?

Is GRI Bio, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is GRI Bio, Inc. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About GRI Bio, Inc.

Company Coordinates